Method for improving yield of MK-7 through farnesyl synthase engineering and fermentation optimization and bacillus subtilis used by method
By integrating high-active farnigyl pyrophosphate synthase and optimizing fermentation conditions, the yield of MK-7 was improved, the problem of low farnigyl pyrophosphate synthase activity in Bacillus subtilis was solved, and the efficient production of MK-7 was achieved .
Patent Information
- Application Number
- CN202411029883.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-30
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-07-30
AI Technical Summary
In the prior art, MK-7 has high production cost and low yield, mainly due to the low activity of farnigyl pyrophosphate synthase in Bacillus subtilis, resulting in the low utilization rate of heptafocal phosphate synthase on substrate FPP and is unable to be effective. Increase the production of MK-7.
By integrating the highly active farnesyl pyrophosphate synthase in Bacillus thermophilic licheniformis with the strong promoter Phbs, assembled at the upstream site of HepS/T encoded operon, the recombinant strain Bacillus subtilis BS018 was constructed, and the fermentation conditions were optimized through single-factor experiments , including adjusting the medium composition and fermentation parameters to improve the yield of MK-7.
The output of MK-7 was increased to 91.1 mg/L, and the output reached 122.0 mg/L under optimized conditions, solving the problem of insufficient carbon flux of farnesyl pyrophosphate, improving the efficiency of side chain synthesis, and providing A feasible solution for industrial production.
Smart Images

Figure CN118909851A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of genetic engineering and biotechnology, and specifically relates to a method for improving the yield of MK-7 through farnesyl synthase engineering and fermentation optimization, and Bacillus subtilis used therein. Background Art
[0002] Heptaquinone (MK-7) is an important form of fat-soluble VK2, mainly composed of 2-methyl-1,4-naphthoquinone as the basic skeleton and a side chain consisting of seven isoprenyl units at the 3-position. Among VK2 homologues, MK-7 has a long half-life in the blood circulation and high bioavailability, and has the most significant effect on the carboxylation of human osteocalcin. Therefore, MK-7 has broad market prospects as a safe and effective dietary supplement. The European Food Safety Authority (EFSA) approved MK-7 as a food and enhanced food additive in 2008; China also approved it to be included in the national nutrient fortification catalog in 2016.
[0003] In the production of MK-7, due to the low natural abundance and high downstream extraction, separation and purification costs, MK-7 is expensive. Today, 90% of the world's VK2 raw materials come from Japan, and the price of imported VK2 per kilogram is 2 to 4 million RMB. At present, the domestic and foreign markets generally use chemical synthesis and traditional fermentation methods to mass produce VK2. The chemical synthesis method usually has complex steps, low yield, low activity, and produces different cis isomers and a large number of by-products, causing environmental pollution. The microbial fermentation method has the advantages of mild conditions and easy availability of raw materials, and the production cost is much lower than that of the chemical synthesis method. The main production strains of MK-7 include Bacillus subtilis, Bacillus natto and Escherichia coli. Among them, Bacillus subtilis is the most studied chassis because it has a clear genetic background, strong stress resistance and is a generally recognized safe (GRAS) food-grade microorganism. Not only that, there is a natural MK-7 synthesis pathway in Bacillus subtilis. When glycerol is used as a substrate, the main pathways include: glycerol dissimilation pathway, classical MK-7 pathway, shikimic acid (SA) pathway, erythritol phosphate (MEP) pathway, pentose phosphate (PPP) pathway, glycolysis pathway (EMP) and tricarboxylic acid (TCA) cycle. At present, most studies focus on strengthening the accumulation of key precursor substances and blocking or weakening the metabolic flow of competing pathways, thereby increasing the accumulation of the target compound MK-7. Although these strategies have significantly improved the microbial production of MK-7, there is still a big gap from the level of industrial production. Studies have shown that the synthesis of farnesyl pyrophosphate FPP by the MEP pathway is not only a synthetic precursor of the MK-7 side chain-heptenyl pyrophosphate (HePP), but also a key precursor of cell wall peptidoglycan undecenyl pyrophosphate (UPP). However, the activity of farnesyl synthase (BSIspA) in B. subtilis is low, only 0.0012 μmol / min / mg, and is usually strictly constrained by its own regulatory system, resulting in low utilization of the substrate FPP by hepS / T. Therefore, how to encourage HepS / T to efficiently utilize the competing precursor FPP is a difficult problem that needs to be solved urgently. Studies have shown that the activity of farnesyl synthase (GSIspA) in thermophilic Bacillus licheniformis can be as high as 4.69 μmol / min / mg, which is 3908 times that of BSIspA. Summary of the invention
[0004] The purpose of the present invention is to provide a method for improving the yield of MK-7 through farnesyl synthase engineering and fermentation optimization and the Bacillus subtilis used therein.
[0005] To achieve the above-mentioned purpose and other related purposes, the technical solution provided by the present invention is: a strain of Bacillus subtilis BS018, wherein the Bacillus subtilis BS018 has been deposited in the China Center for Type Culture Collection (CCTCC), the preservation date is January 2, 2024, and the strain preservation number is CCTCC NO: M2024004.
[0006] To achieve the above-mentioned purpose and other related purposes, the technical solution provided by the present invention is: the use of Bacillus subtilis BS018 in the fermentation preparation of MK-7, wherein the Bacillus subtilis BS018 has been deposited in the China Center for Type Culture Collection (CCTCC) on January 2, 2024, and the strain deposit number is CCTCC NO: M2024004.
[0007] To achieve the above-mentioned purpose and other related purposes, the technical scheme provided by the present invention is: a method for improving the yield of MK-7 through farnesyl synthase engineering and fermentation optimization, inoculating Bacillus subtilis BS018 into LB liquid culture medium, culturing and preparing seed liquid; transferring the seed liquid into fermentation medium, and obtaining fermentation liquid containing MK-7 after culturing; the Bacillus subtilis BS018 has been deposited in the China Center for Type Culture Collection (CCTCC), the preservation date is January 2, 2024, and the strain preservation number is CCTCC NO: M2024004.
[0008] The preferred technical solution is: according to the liquid volume of a 500mL shake flask, the liquid volume in the 500ml shake flask is 40-60mL.
[0009] The preferred technical solution is: the initial pH value of the fermentation medium is 6.8-7.2.
[0010] The preferred technical solution is: the inoculation amount is 7-10%.
[0011] The preferred technical solution is: when glucose or sucrose is used as the quick-acting carbon source, the concentration is 20-30 g / L; the added mass is 1-2.5%.
[0012] The preferred technical solution is: the fermentation medium contains 6-8% by mass of soy peptone and 0.3-0.6% of yeast extract.
[0013] The preferred technical solution is: the fermentation medium contains 0.08-0.12% by mass of KH2PO4 and 0.08-0.12% by mass of MgSO4·7H2O.
[0014] The preferred technical solution is: adding DHNA with a concentration of 0.8-2 mmol / L to the fermentation medium 48 hours after fermentation.
[0015] Due to the application of the above technical solution, the present invention has the following advantages compared with the prior art:
[0016] The invention assembles the highly active farnesyl pyrophosphate synthase (GSIspA) in thermophilic Bacillus licheniformis with the strong promoter Phbs, and integrates it into the upstream site of the HepS / T coding operon hepS-menG-hepT-ndk to obtain the recombinant bacterium Bacillus subtilis BS018. According to the shake flask fermentation test, the yield of MK-7 in Bacillus subtilis BS018 is the highest, reaching 91.1 mg / L. Then, the shake flask culture conditions of the fermentation production of MK-7 by the strain Bacillus subtilis BS018 are optimized by a single factor experiment. The optimized culture medium composition and fermentation conditions are: 2% sucrose, 3% glycerol, 7% soy peptone, 0.4% yeast extract, 0.1% K2HPO4 and 0.1% MgSO4·7H2O, 1mmol / L DHNA, and an initial pH of 7.0. The inoculation volume was 8% (v / v), the liquid volume was 50mL / 500mL, and after culturing at 40°C for 120h, the yield of MK-7 of strain BS018 reached 122.0mg / L. In summary, the protein fusion co-expression strategy effectively solved the problem of insufficient carbon flux of farnesyl pyrophosphate (FPP). This strategy enabled the heptanolone pyrophosphate synthase (HepS / T) to efficiently utilize the precursor FPP, thereby improving the synthesis efficiency of the side chain HepPP. In addition, through single-factor experiments, the optimal fermentation conditions for the synthesis of MK-7 by strain Bacillus subtilis BS018 were found, and its metabolic laws during the fermentation process were explored, providing a strong guarantee for further process research. BRIEF DESCRIPTION OF THE DRAWINGS
[0017] Figure 1The effect of fusion expression of IspA and HepS / T from different sources on MK-7 production and cell growth. In the figure: (A) Synthesis route of side chain HepPP in B. subtilis; (B) Schematic diagram of the construction of recombinant bacteria for in-frame fusion co-expression of IspA and HepS / T from different sources; (C) Growth curve of recombinant strain; (D) MK-7 production in recombinant strain after 120h fermentation. The results are expressed as the average of three replicates, and the error bars are expressed as standard deviations.
[0018] Figure 2 The effect of different initial pH on vitamin K2 production.
[0019] Figure 3 The effect of different inoculum amounts on vitamin K2 production.
[0020] Figure 4 The effect of different liquid volumes on vitamin K2 production.
[0021] Figure 5 Effects of different fast-acting carbon sources on vitamin K2 production. (A) Growth curve of BS018 under different concentrations of glucose and sucrose; (B) Production of MK-7 under different concentrations of glucose and sucrose. The results are expressed as the mean of three replicates, and the error bars are expressed as standard deviations.
[0022] Figure 6 Effects of different concentrations of nitrogen sources on vitamin K2 production. (A) Growth curve of BS018 and MK-7 production under different concentrations of soy peptone; (B) Growth curve of BS018 and MK-7 production under different concentrations of yeast extract. The results are presented as the mean of three replicates, and the error bars are presented as standard deviations.
[0023] Figure 7 Effects of different inorganic salt ions on vitamin K2 production. (A) Growth curve of 6-day fermentation with different concentrations of phosphate added to the fermentation medium; (B) MK-7 production at 4d and 6d after adding different phosphates to the fermentation medium; (C) Strain growth level and MK-7 production under different concentrations of KH2PO4; (D) Effects of different concentrations of MgSO4·7H2O on MK-7 production of the strain. The results are expressed as the mean of three replicates, and the error bars are expressed as standard deviations.
[0024] Figure 8 Effects of different concentrations of DHNA on BS018 biomass and MK-7 yield. (A) Growth curve of 6-day fermentation with different concentrations of DHNA added to the fermentation medium; (B) MK-7 yield after 6-day fermentation with different concentrations of DHNA added to the fermentation medium; The results are presented as the mean of three replicates, and the error bars are presented as standard deviations. DETAILED DESCRIPTION
[0025] The following is a description of the implementation of the present invention by means of specific embodiments. Those skilled in the art can easily understand other advantages and effects of the present invention from the contents disclosed in the embodiments.
[0026] See also Figure 1-8 . It should be noted that the structures, proportions, sizes, etc. illustrated in the drawings of this specification are only used to match the contents disclosed in the specification for people familiar with this technology to understand and read, and are not used to limit the limiting conditions under which the present invention can be implemented. Therefore, they have no substantive technical significance, and any structural modification, change in proportional relationship or adjustment of size. The following examples are provided to better understand the present invention, but are not intended to limit the present invention. The experimental methods in the following examples are all conventional methods unless otherwise specified. The experimental materials used in the following examples are all purchased from conventional biochemical reagent stores unless otherwise specified.
[0027] Deposit of biological material:
[0028] Bacillus subtilis BS018 has been deposited in China Center for Type Culture Collection (CCTCC) on January 2, 2024, with the strain deposit number CCTCC NO: M2024004. Address of China Center for Type Culture Collection: Wuhan University, Wuhan, China.
[0029] Example 1: A method for increasing MK-7 production through farnesyl synthase engineering and fermentation optimization and Bacillus subtilis used therein
[0030] In order to improve the utilization rate of the substrate farnesyl pyrophosphate (FPP) by hepS / T, and allow farnesyl pyrophosphate FPP to be directly utilized by HepS / T without being transported by transporters, constitutive strong promoters were used to assemble with BSispA and GSispA genes, respectively, and integrated and expressed at the upstream site of the operon hepS-menG-hepT-ndk on the chromosome of Bacillus subtilis BS018, respectively obtaining recombinant bacteria Bacillus subtilis BS017 and Bacillussubtilis BS018. Then, the fermentation conditions of the recombinant bacteria to produce MK-7 were studied by single factor experiments, mainly including the initial pH value, inoculation amount, and liquid volume. At the same time, the carbon and nitrogen source components of the culture medium and the supplementary carbon and nitrogen source components, as well as inorganic salts were also optimized by single factors to select the more significant influencing factors.
[0031] 1. Materials and Methods
[0032] (1) Materials and reagents
[0033] Organic reagents used for high performance liquid chromatography (HPLC) analysis were purchased from Sigma-Aldrich. MK-7 standard was purchased from Fujifilm Wako Pure Chemical Industries, Ltd., Japan. Bacterial genome extraction kit was purchased from Tiangen Biochemical Technology (Beijing) Co., Ltd. Plasmid extraction kit and other chemical reagents were purchased from Sangon Biotechnology (Shanghai) Co., Ltd. High-fidelity DNA polymerase PrimeSTAR HSDNA was purchased from Takara (Dalian, China). MonScript TM 5×RTIII All-in-One Mix and MonAmp TM Fast Green qPCR Mix was purchased from Mona Biotechnology Co., Ltd. Sucrose, vitamin E, and reduced glutathione were purchased from Shanghai Sangon Biotechnology Co., Ltd.
[0034] (2) Strains, plasmids, and culture conditions
[0035] All strains and plasmids used in this embodiment are listed in Table 1. In the genetic manipulation experiment, all strains were cultured in LB medium at 37°C and 220rpm. Fermentation production of MK-7: First, Bacillus subtilis was cultured in LB medium at 37°C and 220rpm for 12h, and then the seed liquid was inoculated according to 10% inoculation amount and transferred to a 500mL triangular flask containing 50mL fresh fermentation medium (3% glycerol, 6% soy peptone, 0.5% yeast extract, 0.3% K2HPO4 and 0.05% Mg SO4·7H2O, pH 7.3). Then cultured at 40°C and 250rpm for 120h. 1mL of fermentation liquid was sampled every 6h, and the cell density was measured at a wavelength of 600nm. Antibiotic working concentration: kanamycin (50μg / mL), ampicillin (100μg / mL), spectinomycin (50μg / mL), chloramphenicol (5μg / mL).
[0036] Table 1: Involved strains and plasmids
[0037]
[0038]
[0039] (3) DNA assembly method and Bacillus subtilis transformation method
[0040] The assembly of multiple fragments in DNA assembly was performed by overlapping PCR based on homologous sequences, and the successfully constructed multi-gene fragments were sequenced at Shanghai Sangon Biotechnology Co., Ltd. The homologous fragments or plasmids were transferred into B. subtilis by the sipizizen transformation method.
[0041] (4) Gene promoter replacement and gene integration strain construction
[0042] Method for constructing recombinant bacteria with exogenous gene integration into the genome The site-specific recombination strategy used in this example mainly refers to previous literature reports. First, the kinase encoding gene GsispA of farnesyl synthase (GSIspA) in thermophilic Bacillus licheniformis is artificially synthesized. Using the artificially synthesized GsispA as a template, the GsispA fragment is amplified using primers gsispa3-F / gsispa3-R; then using the B. subtilis genome as a template, primers heps1-F / heps1-R are used to amplify the upstream homology arm sequence of heps - heps upper, and primers gsispa4-F / heps4-R are used to amplify the first 1000bp fragment of heps as the downstream homology arm sequence - heps lower; plasmid p7C6P hbs As a template, primers heps2-F / gsispa2-R were used to amplify lox71-cm-lox66 and P hbs The above four independent fragments were then connected by overlapping PCR to obtain a fusion fragment - heps + lox71-cm-lox66-P hbs +GsispA+heps. Finally, the purified fusion fragment was transformed into BS016 to allow homologous recombination with the chromosome.
[0043] Some colonies were picked from the transformation plate containing chloramphenicol resistance, and the colony PCR was verified with primers heps1-F / gsispa3-R. The positive transformants were those with a band size of 3400bp. Then the pDGC plasmid with the recombinase Cre encoding gene was transferred into the positive transformants, and after 0.5mM IPTG induction, it was spread on a plate with kanamycin resistance. After the colonies grew out, the primers heps1-F / gsispa3-R were used to verify the colony PCR. If the band size was about 2250bp, it meant that the chloramphenicol resistance had been removed. Finally, the positive transformants with the pDGC plasmid were cultured at 50°C overnight, and then spread on a blank LB plate. The transformants were amplified with primers heps1-F / gsispa3-R. After verification, they were sent to Sangon Biotech (Shanghai) Co., Ltd. for sequencing. The overexpression steps of the BSispA gene were similar to those of GsispA.
[0044] Table 2: Primer sequences used for gene modification
[0045]
[0046]
[0047] (5) Shake flask fermentation and growth curve determination
[0048] Fermentation production of MK-7: B. subtilis was inoculated into LB liquid medium, cultured at 37°C, 220r / min for 12h to prepare seed solution. The seed solution was transferred into GSY medium (30mL / L glycerol, 60g / L soy peptone, 5g / L yeast extract, 3g / L K2HPO4, 0.5g / L MgSO4·7H2O, pH 7.3) at a 10% inoculation rate, and cultured at 40°C, 250r / min for 120h. Intermediate samples were taken every 12h and OD was measured. 600 value.
[0049] (6) Optimization of culture conditions
[0050] 1. Optimization of liquid volume
[0051] Based on the fermentation medium, the effect of inoculation volume on the growth of Bacillus subtilis and the fermentation production of MK-7 was explored under the condition that the composition and concentration of the medium were the same and other conditions remained unchanged. Six different inoculation volumes of 50, 60, 70, 80, 90 and 100 mL were set, and three parallel tests were performed in each group. The final MK-7 yield was used as a reference value to determine the optimal liquid volume of the fermentation medium.
[0052] 2. Optimization of initial pH
[0053] Based on the fermentation medium, the effect of initial pH on the growth of Bacillus subtilis and the fermentation production of MK-7 was investigated under the same medium composition and concentration and other conditions. Before autoclaving, the pH of the medium was adjusted to 6.0, 6.5, 7.0, 7.5, 8.0 and 8.5 with 0.1M NaOH or 0.1M HCl. Three parallel tests were performed in each group, and the final MK-7 yield was used as a reference value to determine the initial pH of the fermentation medium.
[0054] 3. Optimization of inoculation amount
[0055] Based on the fermentation medium, the effect of inoculation amount on the growth of Bacillus subtilis and the fermentation production of MK-7 was explored under the condition that the composition and concentration of the medium were the same and other conditions remained unchanged. Four different inoculation amounts of 8%, 10%, 12% and 15% were set, and three parallel tests were performed in each group. The final MK-7 yield was used as a reference value to determine the optimal inoculation amount of the fermentation medium.
[0056] (7) Single factor optimization of fermentation medium
[0057] First, the optimal quick-acting carbon source composition and concentration were screened. Glucose and sucrose were used as quick-acting carbon sources to study the effects of the addition of glucose and sucrose as carbon sources (10, 20, 30, 40 g / L) on cell growth and MK-7 production. Secondly, in order to screen the nitrogen source concentration suitable for BS018 to produce MK-7, different concentration gradients of soy peptone (40, 50, 60, 70, 80 g / L) and yeast extract (4, 5, 6, 7, 8, 9, 10 g / L) were set, and the biomass and MK-7 production were measured to screen the optimal addition amount.
[0058] Then, the effect of inorganic salt ions on MK-7 production was investigated. First, the types of phosphates, including K2HPO4, KH2PO4, Na2HPO4, and NaH2PO4 (concentration of 3 g / L), were optimized. Then, six concentrations of KH2PO4, 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, and 0.6% (w / v), were used to explore their optimal concentrations. In addition, in order to determine the Mg 2+ The optimal addition amount of , 0.1%, 0.2%, 0.3%, 0.4% and 0.5% (w / v) were set for screening. Each experiment was repeated three times and the average value was taken.
[0059] Finally, the effect of adding DHNA, a precursor of MK-7, on strain growth and MK-7 production was investigated. DHNA of different concentrations (1mmol / L, 2mmol / L, 3mmol / L, 4mmol / L) was added to the fermentation medium at 48h of fermentation, and the biomass and MK-7 yield were measured to screen the optimal addition amount. Each experiment was repeated three times and the average value was taken.
[0060] (8) Optimization of the extraction method of MK-7 in fermentation broth
[0061] The main steps of the MK-7 extraction method are as follows:
[0062] 2 mL of bacterial fermentation broth was centrifuged at 9000 × g for 6 min, and 1 mL of supernatant was collected as the fermentation supernatant. 2 mL of a mixture of n-hexane and isopropanol (n-hexane: isopropanol = 2:1, v / v) was added, and the mixture was vortexed vigorously for 20 min. Then, 1 mL of n-butanol was added, and the mixture was vortexed vigorously for another 20 min. The mixture was centrifuged at 5000 × g for 3 min, and the upper organic phase was filtered with an organic filter membrane (0.22 μm pore size) to obtain the MK-7 extract of the fermentation supernatant.
[0063] The wet cells obtained by the above centrifugation were placed in a -80°C refrigerator for freezing, and then vacuum-freeze-dried. 2 mL of ethanol was added to the dry cells, and ultrasonic-assisted extraction was performed for 10 min. The cells were then vortexed vigorously for 20 min, and then centrifuged at 5000 × g for 3 min. The organic phase was collected and filtered with an organic filter membrane (0.22 μm pore size) to obtain the intracellular MK-7 extract.
[0064] (9) Analysis methods
[0065] High performance liquid chromatography (HPLC) was used to detect the yield of MK-7: an ultraviolet detector (SPD-16) was used, the chromatographic column was a reverse phase C-18 column (VP-ODS, 4.6 mm × 250 mm), methanol and dichloromethane were mixed in a volume ratio of 4:1 as the mobile phase, the flow rate was 1 mL / min, the column temperature was set at 35 °C, the detection wavelength was 248 nm, and the injection volume was 20 μL. In the range of 0 to 150 mg / L, the concentration of MK-7 showed a good linear relationship with the absorption peak area (R 2 =0.999).
[0066] 2. Results and Analysis
[0067] (1) Screening and analysis of farnesyl synthase
[0068] By consulting the BRENDA enzyme database, it was found that the specific enzyme activity of farnesene synthase (BsIspA) from Bacillus subtilis was only 0.0012 μmol / min / mg, while the specific enzyme activity of farnesene synthase (GsIspA) from thermophilic Bacillus licheniformis was as high as 4.69 μmol / min / mg, which is 3908 times that of BsIspA.
[0069] (2) Screening and fusion co-expression of farnesyl synthase
[0070] Studies have shown that FPP is not only necessary for cell growth, but also a general substrate for the synthesis of terpenoids, and has a direct impact on the yield of target terpenoids. The synthesis pathway of MK-7's side chain HepPP is as follows: the MEP pathway provides intermediates DMAPP and IPP, FPP is generated under the catalysis of FPP synthase (IspA), and then HepS / T catalyzes FPP to synthesize HepPP. In addition, the HepS / T coding genes hepS and hepT exist in the same operon hepS-menG-hepT-ndk. In addition, there is the DMK-7 methyltransferase coding gene menG, and the nucleoside diphosphate kinase coding gene ndk, of which ndk has no direct connection with the MK-7 synthesis pathway ( Figure 1 A).
[0071] In order to increase the FPP concentration near HepS / T in strain BS016, a strategy of co-localization of IspA and HepS / T in-frame proteins was adopted. In this section, two recombinant bacteria with enhanced FPP flux were constructed. One was to combine the highly active thermophilic Bacillus licheniformis GSispA with the constitutive strong promoter P hbs After ligation, the recombinant bacterium Bacillus subtilis BS018 was obtained by integrating the upstream site of the operon hepS-menG-hepT-ndk. Another method was to construct the endogenous BSispA in the same way to obtain the recombinant bacterium BS017 ( Figure 1 B). The growth curves showed that there was no significant difference in the growth of BS016, BS017 and BS018 in the early stage; however, in the late stable stage, the OD of BS017 600 The value is lower than that of BS016 and BS018; BS018 has the best growth condition among the three ( Figure 1 C). It is possible that the successful integration and expression of exogenous GSispA in the genome alleviated the accumulation of toxic intermediates DMAPP and IPP, thereby alleviating the burden on cell growth. From the MK-7 yield test, it was found that after 120h fermentation, the MK-7 yield in Bacillus subtilis BS018 reached 91.1mg / L, which was 1.1 times that of MK-7 in strain BS016, but the MK-7 yield in BS017 was lower than that in BS016. It is possible that the endogenous BSispA is affected by the host's own feedback inhibition ( Figure 1 D). The above results show that the exogenous introduction of GsIspA and HepS / T fusion expression is an effective strategy to enhance MK-7 synthesis, so that IspA and HepS / T proteins form a chimera, and the delivery of FPP to HepS / T has excellent kinetic characteristics, avoiding the waste caused by the free diffusion of intermediates into the large amount of fluid in the cytoplasm. Therefore, this paper selected the strain BS018 with strong MK-7 synthesis ability as the final production strain.
[0072] (3) Fermentation condition optimization results and analysis
[0073] 1. Optimization of liquid volume
[0074] The growth of Bacillus subtilis requires a certain amount of oxygen, and the amount of liquid will affect the dissolved oxygen. 50, 60, 70, 80, 90 and 100 mL of fermentation medium with an initial pH of 7.0 were respectively added to 500 mL shaking flasks, with an inoculation rate of 8%, and cultured at 40°C, 250 rpm shaking for 6 days to ferment MK-7. The results are shown in Figure 4As shown in the figure, when the liquid volume was 50 mL, the MK-7 yield was 83.45 mg / L, which was significantly higher than that of other control groups. Therefore, when the liquid volume was 50 mL in a 500 mL shake flask, it was most conducive to the synthesis of MK-7.
[0075] 2. Optimization of initial pH
[0076] The pH of the fermentation medium has an important influence on the enzymatic reaction and the charge and membrane permeability of the bacterial cell membrane. The synthesis of the product also requires a certain pH value. During the growth of microorganisms, the pH value of the environment will change greatly due to the metabolism. Therefore, adjusting the appropriate initial pH value of the medium is of great significance to the production of MK-7. B. subtilis was cultured under different initial pH conditions to study the effect of pH on the yield of MK-7 in B. subtilis. Figure 2 It can be seen that too high or too low pH is not conducive to the production of vitamin K2. When the pH is 7.0, the output of vitamin K2 is the highest, which is 98.49 mg / L, so 7.0 is selected as the optimal fermentation pH value.
[0077] 3. Optimization of inoculation amount
[0078] Properly increasing the inoculum size in the fermentation medium can reduce the time it takes for B. subtilis to reach the stable stage. However, if the inoculum size is too high, the strain will grow too fast, the nutrients will be consumed quickly, and the bacteria will enter the decay stage early, thus affecting the synthesis of the fermentation product. However, if the inoculum size is too small, the fermentation cycle of Bacillus subtilis will be prolonged, so the appropriate inoculum size is also an important factor in determining the fermentation level. Under the premise that other fermentation conditions remain unchanged, four different inoculum sizes of 8%, 10%, 12% and 15% are set respectively, and fermentation culture is carried out under the same conditions. Figure 3 The results showed that when the inoculation amount was 8%, the MK-7 yield was 109.58 mg / L, indicating that an inoculation amount of 8% was most conducive to the production of vitamin K2.
[0079] (4) Culture medium composition optimization results and analysis
[0080] 1. Impact of carbon source
[0081] Optimization of culture medium composition is an effective method to improve MK-7 production. Carbon is the most critical culture medium component because it is the energy source for microorganisms and plays an important role in growth and the production of primary and secondary metabolites. Different concentrations of glucose and sucrose (10, 20, 30, 40 g / L) were used to study their effects on cell growth and MK-7 production. Figure 5It can be seen that when glucose and sucrose are used as carbon sources, at each concentration, the cell density and MK-7 yield using sucrose as a quick-acting carbon source are greater than those using glucose. With the increase of sucrose concentration, the cell density shows a trend of increasing first and then decreasing, but it is higher than the control group. When the sucrose concentration is 20g / L, the cell density is the largest, which is 23.96. At this time, the MK-7 yield is 72.65mg / L, which is 7.2% higher than the control group (10g / L). With the increase of glucose concentration, the cell density increases significantly, but the increase in MK-7 yield is not obvious.
[0082] Different carbon sources enter the metabolic pathway in different ways. Glucose can be directly used by microorganisms to enter the metabolic pathway. Glucose is converted into glucose-6-phosphate and fructose-6-phosphate under the catalysis of hexokinase to enter the metabolic pathway. Sucrose needs to be hydrolyzed into one molecule of fructose and one molecule of glucose under the action of sucrase before entering the metabolic pathway under the catalysis of the enzyme. And different carbon sources are metabolized in different pathways after entering the metabolic pathway, thereby providing energy and required precursors for the growth metabolism and product synthesis of microorganisms. Therefore, Bacillus subtilis shows significant differences in biomass and MK-7 yield using different carbon sources (glucose, sucrose), which may be caused by the following reasons: First, the enzyme activity or enzyme amount of different carbon sources entering the metabolic pathway is different. Secondly, when the disaccharide substrate sucrose is used as the carbon source, it is used while decomposing and generating glucose, which alleviates the inhibitory effect caused by excessive glucose concentration.
[0083] In summary, 2% sucrose promoted cell growth and MK-7 synthesis, and 2% sucrose was selected as the fast-acting carbon source in the fermentation medium.
[0084] 2. Impact of nitrogen source
[0085] The optimal nitrogen source for MK-7 production was investigated. The use of a combination of yeast extract and soy peptone was beneficial in promoting the production of MK-7. Yeast extract can be used as a nutritional supplement for the production of value-added products because it is easily utilized by bacteria. Therefore, the effects of different yeast extract concentrations (4, 5, 6, 7, 8, 9, 10 g / L) on cell density and MK-7 production were first studied to further improve the MK-7 production of strain BS018. Figure 6 B shows that when the yeast extract addition amount is 9g / L, the cell density reaches the highest value of 38.92, but the MK-7 yield reaches the peak value of 53.07mg / L when the yeast extract addition amount is 4g / L. When 8g / L yeast extract is added, the MK-7 yield drops sharply, indicating that only the addition of appropriate concentration of yeast extract is beneficial to increase the MK-7 yield. It should be noted that high concentration of yeast extract leads to heavy metabolic burden and higher osmotic pressure of bacteria, which is not conducive to the normal physiological metabolism of bacteria, thereby reducing cell density and MK-7 titer.
[0086] Secondly, the optimal concentration of nitrogen source in the starting medium was studied using 60 g / L soy peptone as the starting nitrogen source. Figure 6 As can be seen from Figure A, when 7% (W / V) soy peptone was used as the nitrogen source, the cell density and MK-7 production of BS018 reached the highest 30.2 and 72 mg / L, respectively. This result indicates that 7% (W / V) soy peptone may be the best nitrogen source for cell growth and MK-7 production of strain BS018.
[0087] Therefore, 7% soy peptone and 0.4% yeast extract were the best nitrogen sources for strain BS018 to produce MK-7.
[0088] 3. Optimization of metal ions
[0089] Inorganic salts, especially some metal ions, play an indispensable role in the growth of microorganisms. They participate in various metabolic activities in microbial cells and constitute the coenzyme center of various enzyme systems. Keeping other components in the fermentation medium unchanged, K2HPO4, KH2PO4, Na2HPO4, and NaH2PO4 were added separately as inorganic salts to examine the effect on the fermentation production of vitamin K2. Figure 7 A. Figure 7 From B, we can see that the effect of KH2PO4 on MK-7 synthesis is significantly higher than that of the other three inorganic salts, so KH2PO4 was selected for the next concentration optimization experiment. Different concentration gradients of KH2PO4 (0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%) were set to study its effect on Bacillus subtilis biomass and MK-7 production. When the KH2PO4 concentration was 0.1%, the MK-7 production was 53.43 mg / L, which was significantly higher than that of other control groups ( Figure 7 C), so 0.1% was selected for the next optimization experiment.
[0090] Mg 2+ It is an activator of many enzymes and is widely involved in material metabolism and energy metabolism. Therefore, the effects of 0.1%, 0.2%, 0.3%, 0.4% and 0.5% (w / v) MgSO4·7H2O on the production of MK-7 were studied. The results showed that when the concentration of MgSO4·7H2O was 0.1%, the yield of MK-7 was 122mg / L ( Figure 7 Therefore, this concentration was selected for subsequent experiments.
[0091] 4. Addition of DHNA, the precursor of MK-7
[0092] 1,4-dihydroxy-2-naphthoic acid (DHNA) acts as a precursor for the synthesis of the naphthoquinone ring core of MK, so its addition as an important precursor may promote the fermentation synthesis of MK. DHNA of different concentrations (1mmol / L, 2mmol / L, 3mmol / L, 4mmol / L) was added to the fermentation medium at 48 hours of fermentation to observe the effect of the precursor on the growth of BS018 bacteria and the synthesis of MK-7. The experiment used a normal fermentation medium without any additives as the control group. The results are as follows Figure 8 shown.
[0093] like Figure 8 As shown in A, compared with the control group, the bacterial counts at the four concentrations all showed a trend of increasing first and then decreasing. Among them, when the addition amount was 4mmol / L, the bacterial count decreased rapidly in the late fermentation period, considering the toxicity of the addition amount to bacterial growth. Figure 8 B shows that when the additive concentration is 2mmol / L, 3mmol / L, and 4mmol / L, the yield of synthesized MK-7 is lower than that of the control group. When the additive amount is 4mmol / L, the MK-7 yield is the lowest, which is 41.38mg / L, significantly lower than 82.66mg / L of the control group.
[0094] When 1mmol / L DHNA was added, the yield of MK-7 was the highest, 92.36mg / L, which was 10.5% higher than that of the control group. Therefore, the addition of 1mmol / L was selected for subsequent experiments.
[0095] The above description is only used to explain the preferred embodiments of the present invention, and is not intended to limit the present invention in any form. Therefore, any modifications or changes made to the present invention under the same inventive spirit should still be included in the scope of protection intended by the present invention.
Claims
1. A strain of Bacillus subtilis BS018, characterized in that: The Bacillus subtilis BS018 has been deposited in the China Center for Type Culture Collection (CCTCC) on January 2, 2024, and the strain deposit number is CCTCC NO: M2024004.
2. Application of Bacillus subtilis BS018 in fermentation preparation of MK-7, characterized in that: The Bacillus subtilis BS018 has been deposited in the China Center for Type Culture Collection (CCTCC) on January 2, 2024, and the strain deposit number is CCTCC NO: M2024004.
3. A method for increasing MK-7 production by farnesyl synthase engineering and fermentation optimization, characterized in that: Bacillus subtilis BS018 is inoculated into LB liquid culture medium and cultured to prepare seed solution; the seed solution is transferred into fermentation medium, and after culture, a fermentation solution containing MK-7 is obtained; the Bacillus subtilis BS018 has been deposited in the China Center for Type Culture Collection (CCTCC), the preservation date is January 2, 2024, and the strain preservation number is CCTCC NO: M2024004.
4. The method for increasing MK-7 production by farnesyl synthase engineering and fermentation optimization according to claim 3, characterized in that: According to the liquid volume of a 500mL shake flask, the liquid volume in a 500mL shake flask is 40-60mL.
5. The method for increasing MK-7 production by farnesyl synthase engineering and fermentation optimization according to claim 3, characterized in that: The initial pH of the fermentation medium was 6.8-7.
2.
6. The method for increasing MK-7 production by farnesyl synthase engineering and fermentation optimization according to claim 3, characterized in that: The inoculation rate is 7-10%.
7. The method for increasing MK-7 production by farnesyl synthase engineering and fermentation optimization according to claim 3, characterized in that: When glucose or sucrose is used as a fast-acting carbon source, the concentration is 20-30 g / L; the added mass is 1-2.5%.
8. The method for increasing MK-7 production by farnesyl synthase engineering and fermentation optimization according to claim 3, characterized in that: The fermentation medium contains 6-8% by mass of soybean peptone and 0.3-0.6% of yeast extract.
9. The method for increasing MK-7 production by farnesyl synthase engineering and fermentation optimization according to claim 3, characterized in that: The fermentation medium contains 0.08-0.12% by mass of KH2PO4 and 0.08-0.12% by mass of MgSO4·7H2O.
10. The method for increasing MK-7 production by farnesyl synthase engineering and fermentation optimization according to claim 3, characterized in that: DHNA at a concentration of 0.8-2 mmol / L was added to the fermentation medium at 48 hours of fermentation.
Citation Information
Patent Citations
Method for synthesizing MK-7 by applying bacillus subtilis colony response control system
CN110157749A
Recombinant bacillus subtilis for increasing yield of MK-7 and application of recombinant bacillus subtilis
CN110229772A
Method for constructing engineering bacteria for efficiently biosynthesizing vitamin K2
CN116064633A
Method for obtaining bacillus subtilis with high yield of vitamin K2 by regulating and controlling upps sites
CN116083470A
Lactococcus lactis for MK-n production and construction method and application thereof
CN117603891A
